Abstract:Prior studies demonstrated an equivocal conclusion about the association between the level of retinol-binding protein 4 (RBP4)/visfatin and periodontitis patients with obesity. The aim of our study (Prospero ID: CRD42023469058) was to systematically review the available articles linking the biofluid levels of RBP4/visfatin to the comorbidity of periodontitis and obesity. Clinical trials were screened in accordance with specific inclusion criteria from seven databases up to November 2023. A quality assessment was performed with the Newcastle–Ottawa Scale and ROBINS-I tools for observational and interventional trials, respectively. The standard mean difference (SMD) with a 95% confidence interval (CI) related to the RBP4 level was recorded; the other indicators related to the visfatin level were measured via the mean difference (MD) with the corresponding 95% CI, and Fisher’s Z transformation was measured to reveal the association using Review Manager 5.4. The current evidence was based on five observational studies and two interventional studies. All of them were included in the systematic review, and six of them were in the meta-analysis. Statistical analysis indicated that there was no significant difference in the circulating levels of RBP4 in the periodontitis patients with obesity or without, who were labeled as OP or NP, respectively (155 OP-107 NP: SMD = 1.38; 95% CI: −0.18–2.94, p = 0.08), as well as the periodontal healthy patients with a normal weight, who were labelled as NnP (116 OP-79 NnP: SMD = 6.76; 95% CI: −5.34–18.87, p = 0.27). Meanwhile, a significant higher level of serum visfatin was found in the OP patients than that of the NP (86 OP-45 NP: MD = 4.21; 95% CI: 2.65–5.77, p < 0.00001)/NnP (164 OP-88 NnP: MD = 13.02; 95% CI: 7.34–18.70, p < 0.00001) group. In addition, a positive association was observed between the serum RBP4 and body mass index/clinical attachment loss (CAL). And, then, there was a positive association between the serum visfatin and periodontal parameters, including the probing depth, CAL, and plaque index, as well as metabolic parameters, including the total cholesterol, triglycerides, fasting blood glucose, and low-density lipoprotein cholesterol. Here, the circulating RBP4 level was not independently related to the comorbidity of periodontitis and obesity, while serum visfatin was significantly associated with periodontitis and obesity. Notably, the positive association between circulating RBP4/visfatin and the periodontal parameters/metabolic parameters firmly suggested that the higher severity of the obese or periodontal status was associated with an elevated level of serum visfatin or RBP4 in the OP group. With more rigorous longitudinal research, the exact causations between RBP4/visfatin and the patients affected by obesity and periodontitis could be disentangled. RBP4 and visfatin might be novel, enlightening prospective bio-indexes for the targeted treatment of comorbidities.

Serum levels of retinol binding protein 4, adiponectin and tumor necrosis factor-alpha and their correlations in patients with obesity and type 2 diabetes mellitus

Significance of RBP4 in Patients with Gestational Diabetes Mellitus: a Case-Control Study of Han Chinese Women

Change and Clinical Significance of Serum Retinal Binding Protein-4 Levels in Patients with Obesity and Type 2 Diabetes 1

Change of Retinol Binding Protein-4 Concentrations in Patients with Type 2 Diabetes Mellitus and Its Relationship with Glucose and Lipid Metabolism

Association of Serum Retinol-Binding Protein 4 and Visceral Adiposity in Chinese Subjects with and Without Type 2 Diabetes

The Relationship Between Retinol-Binding Protein 4 Concentrations and Gestational Diabetes Mellitus in Chinese Women

Serum Retinol Binding Protein 4 and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity: a cross-sectional study

Relationship between adipose cytokines and metabolic syndrome in newly diagnosed type 2 diabetes mellitus patients

Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study

Serum Resistin and Adiponectin Concentrations in Patients with Overweight and Obesity

Correlation Between Serum Levels of Adipose Triglyceride Lipase and Obesity and Diabetes Mellitus

Sexual Dimorphism in the Association of Serum Retinol-Binding Protein-4 With Long-Term Dynamic Metabolic Profiles in Non-Diabetes

Serum tumor necrosis factor-α level in patients with type 2 diabetes mellitus and its correlative analysis with obesity

Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study

Serum Retinol‐binding Protein 4 is Associated with Insulin Secretion in Chinese People with Normal Glucose Tolerance

Effect of RBP4 Gene Variants on Circulating RBP4 Concentration and Type 2 Diabetes in a Chinese Population

Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population

Serum Leptin, Resistin, and Adiponectin Levels in Obese and Non-Obese Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Population-Based Study.

Expression and Regulation of Retinol Binding Protein 4 Mrna in Human Adipose Tissue in Obese and Type 2 Diabetics

Retinol-Binding Protein 4 and Visfatin Levels in Patients with Periodontitis and Obesity/Overweight: A Systematic Review and Meta-Analysis